350 related articles for article (PubMed ID: 30612568)
1. Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
Chang J; Lin G; Ye M; Tong D; Zhao J; Zhu D; Yu Q; Zhang W; Li W
BMC Cancer; 2019 Jan; 19(1):15. PubMed ID: 30612568
[TBL] [Abstract][Full Text] [Related]
2. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.
Tuncel T; Ozgun A; Emirzeoglu L; Celik S; Bilgi O; Karagoz B
Asian Pac J Cancer Prev; 2014; 15(15):6421-3. PubMed ID: 25124636
[TBL] [Abstract][Full Text] [Related]
3. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Barth DA; Riedl JM; Posch F; Smolle MA; Kasparek AK; Niedrist T; Szkandera J; Stöger H; Pichler M; Stotz M; Gerger A
Clin Transl Oncol; 2019 Aug; 21(8):1034-1043. PubMed ID: 30671731
[TBL] [Abstract][Full Text] [Related]
6. Elevated mean platelet volume predicts poor prognosis in colorectal cancer.
Li N; Yu Z; Zhang X; Liu T; Sun YX; Wang RT; Yu KJ
Sci Rep; 2017 Aug; 7(1):10261. PubMed ID: 28860547
[TBL] [Abstract][Full Text] [Related]
7. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
[TBL] [Abstract][Full Text] [Related]
8. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
Matsuda A; Yamada T; Matsumoto S; Sakurazawa N; Kawano Y; Shinozuka E; Sekiguchi K; Suzuki H; Yoshida H
Anticancer Res; 2019 Aug; 39(8):4343-4350. PubMed ID: 31366528
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
Cruz-Ramos M; Del Puerto-Nevado L; Zheng B; López-Bajo R; Cebrian A; Rodríguez-Remirez M; García-García L; Solanes-Casado S; García-Foncillas J
J Geriatr Oncol; 2019 Sep; 10(5):742-748. PubMed ID: 30327283
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma.
Kilincalp S; Çoban Ş; Akinci H; Hamamcı M; Karaahmet F; Coşkun Y; Üstün Y; Şimşek Z; Erarslan E; Yüksel İ
Eur J Cancer Prev; 2015 Jul; 24(4):328-33. PubMed ID: 25304028
[TBL] [Abstract][Full Text] [Related]
13. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.
Inagaki N; Kibata K; Tamaki T; Shimizu T; Nomura S
Lung Cancer; 2014 Jan; 83(1):97-101. PubMed ID: 24189108
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
16. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
[No Abstract] [Full Text] [Related]
17. Clinical Characteristics of Colorectal Cancer Patients in terms of Selected Platelet Indices.
Copija A; Nowakowska-Zajdel E; Janion K; Walkiewicz K
Dis Markers; 2020; 2020():6145604. PubMed ID: 33133303
[TBL] [Abstract][Full Text] [Related]
18. Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study.
Wu YY; Zhang X; Qin YY; Qin JQ; Lin FQ
BMC Cancer; 2019 Apr; 19(1):314. PubMed ID: 30947696
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
20. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
